CD8A and malignant colon neoplasm: Concerning CD8 T cells, the peripheral blood-circulating CX3CR1+ CD8 T-cell frequency is associated with the ICB (anti-PD-1, anti-CTLA-4 or both) efficacy in murine colon cancer models [88].